4th Circ. Backs Dismissal of Takeda Whistleblower Suit
By Ciaran McEvoy ( January 11, 2013, 7:42 PM EST) -- The Fourth Circuit on Friday ruled that a Takeda Pharmaceuticals North America Inc. sales leader could not proceed with his whistleblower lawsuit against the pharmaceutical giant accusing it of allowing off-label use to overbill Medicare for a stomach acid drug because his thrice-amended complaint failed to allege specific violations of the False Claims Act....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.